CA3145200A1 - Pharmaceutical composition for treating influenza virus infections - Google Patents

Pharmaceutical composition for treating influenza virus infections Download PDF

Info

Publication number
CA3145200A1
CA3145200A1 CA3145200A CA3145200A CA3145200A1 CA 3145200 A1 CA3145200 A1 CA 3145200A1 CA 3145200 A CA3145200 A CA 3145200A CA 3145200 A CA3145200 A CA 3145200A CA 3145200 A1 CA3145200 A1 CA 3145200A1
Authority
CA
Canada
Prior art keywords
influenza virus
infectious disease
intraoral
virus infectious
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3145200A
Other languages
English (en)
French (fr)
Inventor
Syou Okiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aillis Inc
Original Assignee
Aillis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aillis Inc filed Critical Aillis Inc
Publication of CA3145200A1 publication Critical patent/CA3145200A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/24—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the mouth, i.e. stomatoscopes, e.g. with tongue depressors; Instruments for opening or keeping open the mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147—Holding or positioning arrangements
    • A61B1/00148—Holding or positioning arrangements using anchoring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Theoretical Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Quality & Reliability (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
CA3145200A 2019-07-03 2020-06-30 Pharmaceutical composition for treating influenza virus infections Pending CA3145200A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019124750 2019-07-03
JP2019-124750 2019-07-03
PCT/JP2020/025652 WO2021002355A1 (ja) 2019-07-03 2020-06-30 インフルエンザウイルス感染症を治療するための医薬組成物

Publications (1)

Publication Number Publication Date
CA3145200A1 true CA3145200A1 (en) 2021-01-07

Family

ID=74101322

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3145200A Pending CA3145200A1 (en) 2019-07-03 2020-06-30 Pharmaceutical composition for treating influenza virus infections

Country Status (9)

Country Link
US (2) US12245754B2 (https=)
EP (2) EP3995149A4 (https=)
JP (2) JPWO2021002355A1 (https=)
KR (1) KR20220034130A (https=)
CN (2) CN114340637A (https=)
BR (1) BR112021026839A2 (https=)
CA (1) CA3145200A1 (https=)
MX (1) MX2021016040A (https=)
WO (1) WO2021002355A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01148233A (ja) * 1987-12-07 1989-06-09 Olympus Optical Co Ltd マウスピース
JP3510343B2 (ja) * 1994-08-23 2004-03-29 オリンパス株式会社 電子内視鏡
US6257238B1 (en) * 2000-05-25 2001-07-10 Nizam M. Meah Bite block for upper gastrointestinal endoscopy with tongue depressor
FR2824723B1 (fr) * 2001-05-15 2003-08-15 Univ Joseph Fourier Embout destine a un dispositif d'evaluation de la sensibilite du pharynx, dispositif le comportant et procede d'utilisation
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2005104926A1 (ja) * 2004-04-30 2005-11-10 J. Morita Manufacturing Corporation 生体観察機器、口腔内撮影装置及び医療用診療器具
WO2009023356A2 (en) * 2007-05-25 2009-02-19 Omega-Biopharma (H.K.) Limited Materials and methods for treating influenza infections
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
JP5145587B2 (ja) * 2007-12-27 2013-02-20 晃一 角田 口腔挿入具および口腔咽頭鏡装置
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
US10022449B2 (en) * 2009-12-22 2018-07-17 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
EP2868096B1 (en) * 2012-06-27 2020-08-05 Zipline Health, Inc. Devices, methods and systems for acquiring medical diagnostic information and provision of telehealth services
US9555094B2 (en) 2012-07-23 2017-01-31 The Institute Of Biological Resources Isolated nucleic acid for the production of a vaccine against virus
HK1209646A1 (en) 2012-12-28 2016-04-08 日本国立感染症研究所 Nasal influenza vaccine composition
MX387277B (es) 2013-03-14 2025-03-12 Contrafect Corp Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
US10632010B2 (en) * 2014-04-01 2020-04-28 Oventus Medical Limited Breathing assist device
EP3294106B1 (en) * 2015-05-12 2020-08-26 Zipline Health, Inc. Devices for acquiring medical diagnostic information and provision of telehealth services
CA2986363C (en) * 2015-05-19 2021-10-26 Tyto Care Ltd. Systems and methods for throat imaging
JP6837258B2 (ja) * 2016-11-18 2021-03-03 国立大学法人鳥取大学 喉頭鏡及び喉頭鏡用ブレード
JP6844088B2 (ja) * 2017-01-25 2021-03-17 株式会社メドレー 医療情報提供方法、医療情報提供装置、及びプログラム
US11104689B2 (en) * 2017-09-18 2021-08-31 Sunshine Lake Pharma Co., Ltd. Influenza virus replication inhibitor and use thereof
JP7267608B2 (ja) 2017-12-28 2023-05-02 アイリス株式会社 口内撮影装置、医療装置及びプログラム
CN109504721B (zh) * 2018-12-26 2021-07-09 杭州科巢生物科技有限公司 一种抗流感药物的合成方法

Also Published As

Publication number Publication date
US20250176815A1 (en) 2025-06-05
EP4599758A2 (en) 2025-08-13
JPWO2021002355A1 (https=) 2021-01-07
EP3995149A4 (en) 2023-07-19
CN114340637A (zh) 2022-04-12
KR20220034130A (ko) 2022-03-17
CN119679357A (zh) 2025-03-25
US12245754B2 (en) 2025-03-11
EP3995149A1 (en) 2022-05-11
BR112021026839A2 (pt) 2022-02-22
EP4599758A3 (en) 2025-11-05
JP2025084816A (ja) 2025-06-03
US20220361741A1 (en) 2022-11-17
WO2021002355A1 (ja) 2021-01-07
MX2021016040A (es) 2022-03-11

Similar Documents

Publication Publication Date Title
US11523741B2 (en) Intraoral imaging apparatus, medical apparatus, and program
Singh et al. Foot-and-mouth disease virus: immunobiology, advances in vaccines and vaccination strategies addressing vaccine failures—an Indian perspective
TW201616441A (zh) 用於測定一藥學製劑之投藥方案的遵從性及有效性之系統及方法
TW200612299A (en) Computerized drug delivery platform
Butt et al. Dental healthcare amid the covid-19 pandemic
US20250176815A1 (en) Pharmaceutical Composition For Treating Influenza Virus Infections
Graaf et al. Fluarix quadrivalent vaccine for influenza
WO2019131328A1 (ja) 口内撮影補助具、及びその口内撮影補助具を含む医療装置
Doulberis et al. Does COVID-19 Vaccination Warrant the Classical Principle “ofelein i mi vlaptin”?
Haupt et al. Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice
Peskersoy et al. Evaluation of proximal contact tightness and contact area of posterior composite resin restorations
Elliott et al. Systematic review of equine influenza a virus vaccine studies and meta-analysis of vaccine efficacy
Rappuoli et al. Influenza vaccines for the future
Maltseva et al. Systemic and mucosal antibody responses to SARS-CoV-2 variant-specific prime-and-boost and prime-and-spike vaccination: A comparison of intramuscular and intranasal bivalent vaccine administration in a murine model
Yue et al. Study of the effects of several SARS-CoV-2 structural proteins on antiviral immunity
Najjar et al. COVID-19 Vaccination: The mainspring of challenges and the seed of remonstrance
EP4261833A1 (en) Guidance for a drug delivery process
Nazareth et al. Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients
Gautret et al. One-week, two-visit, double-dose, intra-dermal (22ID) rabies vaccination schedule for travelers: Time/dose sparing, effective but “off label”
Muhammad et al. Physicians’ Perception About the Side Effects of COVID-19 Vaccine and Their Role in Vaccination Program
Žegarac Universal Influenza Vaccine: A Game Changer in Prevention
Žegarac Overcoming Challenges to Create a Universal Influenza Vaccine
Zuccotti et al. Strategies for preventing influenza: future perspectives in influenza vaccine technology
Finn Clinical trials of influenza vaccines: special challenges
Khanna et al. Vaccines for pandemic influenza A H1N1 (2009): where do we stand?

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240502

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20250203

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250612

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20251014

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251217

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20260217